Jesy Nelson’s Advocacy for Baby SMA Screening
Singer Jesy Nelson, known for her time in Little Mix, has taken a stand to ensure that all newborns are tested for Spinal Muscular Atrophy (SMA). She was recently affected by this issue when she learned that her twin daughters, Ocean and Story, have SMA—a rare muscle disease that may prevent them from ever walking.
In an emotional interview, Jesy expressed her frustration about the lack of screening for SMA at birth. She noted that current newborn tests include screening for ten other conditions, but not SMA. “If this condition can be diagnosed early, it could change everything for these children,” she stated.
Since the diagnosis, Jesy has undergone a steep learning curve in caring for her daughters. “It’s overwhelming while trying to be their mom and not just their caregiver,” she shared. Her journey has been challenging, but she finds comfort in the fact that the twins have each other.
The Importance of Early Detection
SMA affects the motor neurons in the spinal cord, leading to muscle weakness and atrophy. Early diagnosis is crucial, as treatments like gene therapy have shown to be more effective when administered shortly after birth. According to SMA UK, timely treatment can help improve mobility and overall quality of life, but irreversible damage can occur if treatment is delayed.
In 2021, the NHS approved Zolgensma, a groundbreaking gene therapy aimed at treating SMA, but the window for effectiveness is narrow. Health Secretary Wes Streeting has acknowledged Jesy’s concerns and is exploring the integration of genomic medicine into routine screenings.
Starting in the spring, Scotland will begin routine screenings for SMA in newborns. Discussions are ongoing about whether to implement similar measures across the rest of the UK. This reflects a growing recognition of the need for better screening practices.
Community and Awareness
On social media, many have rallied behind Jesy’s campaign, sharing their own experiences with SMA and advocating for change. Parents and health advocates have chimed in to emphasize the critical nature of early identification and treatment.
Jesy expressed gratitude for the support she has received, saying, “I feel like I have a responsibility to raise awareness. If my story can help even one child, then it’s worth it.”
Looking Ahead
While the journey is daunting, Jesy remains hopeful. She believes in the resilience of her daughters and the importance of positive energy. “They are still smiling, and that’s what matters most,” she stated. Her commitment to advocating for SMA awareness may pave the way for vital changes in newborn screening protocols.
As conversations around SMA gain momentum, the hope is that more families will have access to life-changing treatments from birth, making a difference in the lives of children affected by this rare disease.
For more information on SMA and gene therapy, you can visit SMA UK.
